scholarly article | Q13442814 |
P356 | DOI | 10.1002/J.1552-4604.1990.TB03481.X |
P698 | PubMed publication ID | 2189903 |
P2093 | author name string | Singh S | |
Svetkey LP | |||
Weir MR | |||
Douglas J | |||
Woodward DL | |||
Chen CF | |||
DeQuattro V | |||
Saunders E | |||
Vlachkis ND | |||
Wiedl SC | |||
P2860 | cites work | Reversal of target-organ involvement in systemic hypertension: a pharmacologic experience | Q39483977 |
A comparison of verapamil and propranolol for the initial treatment of hypertension. Racial differences in response | Q44892188 | ||
Efficacy and safety of sustained-release diltiazem as replacement therapy for beta blockers and diuretics for stable angina pectoris and coexisting essential hypertension: a multicenter trial | Q46438918 | ||
Pharmacokinetics of nilvadipine in healthy volunteers. | Q51630558 | ||
Immediate and short-term hemodynamic effects of diltiazem in patients with hypertension. | Q54437072 | ||
P433 | issue | 5 | |
P921 | main subject | nilvadipine | Q7037489 |
pharmacology | Q128406 | ||
P304 | page(s) | 425-437 | |
P577 | publication date | 1990-05-01 | |
P1433 | published in | The Journal of Clinical Pharmacology | Q7743562 |
P1476 | title | Evaluation of the clinical pharmacology of nilvadipine in patients with mild to moderate essential hypertension | |
P478 | volume | 30 |
Q50802933 | Apolipoprotein E genotype-specific short-term cognitive benefits of treatment with the antihypertensive nilvadipine in Alzheimer's patients--an open-label trial. |
Q43864968 | Carbamazepine decreases antihypertensive effect of nilvadipine |
Q53322014 | Demonstration of safety in Alzheimer's patients for intervention with an anti-hypertensive drug Nilvadipine: results from a 6-week open label study. |
Q40503549 | Nilvadipine. A review of its pharmacodynamic and pharmacokinetic properties, therapeutic use in hypertension and potential in cerebrovascular disease and angina |